New Age Alpha Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.75M Sell
34,467
-2,896
-8% -$675K 0.37% 54
2026
Q1
$9.13M Buy
37,363
+2,641
+8% +$615K 0.43% 45
2025
Q4
$7.19M Buy
34,722
+3,426
+11% +$677K 0.31% 74
2025
Q3
$5.8M Sell
31,296
-416
-1% -$71.3K 0.24% 108
2025
Q2
$4.84M Buy
31,712
+31,582
+24,294% +$4.85M 0.21% 128
2025
Q1
$21.6K Sell
130
-4,467
-97% -$699K ﹤0.01% 872
2024
Q4
$665K Buy
+4,597
New +$712K 0.03% 493

Other funds holding JNJ

New Age Alpha Advisors's JNJ Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Johnson & Johnson (JNJ) stake by 7.8% in Q2 2026, selling an estimated $675K and leaving 34,467 shares worth $8.75M. The position accounts for 0.37% of the portfolio, ranked #54.

New Age Alpha Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.13M in Q1 2026. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • New Age Alpha Advisors held 34,467 shares of Johnson & Johnson worth $8.75M as of Q2 2026.
  • New Age Alpha Advisors sold 2,896 Johnson & Johnson shares in Q2 2026, an estimated $675K.
  • Johnson & Johnson made up 0.37% of New Age Alpha Advisors's portfolio in Q2 2026, its #54 holding.
  • New Age Alpha Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Johnson & Johnson position peaked at $9.13M in Q1 2026.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.